Rx ad spend fell 18.4% in 2008: Nielsen

Share this article:
Pharmaceutical industry ad spend fell 18.4% in 2008 to $4.3 billion in the US, according to The Nielsen Company. 

Johnson & Johnson, the sole drug company among the nation's top 10 advertisers, spent $1.2 billion on advertising—down 5.4% over 2007 spending. 

Overall, US ad spend declined 2.6% for the year to $136 billion, and the top 10 advertisers collectively spent 15% less than in 2007. 

Of the top 10 advertising sectors, the drug industry, ranked second, posted the largest decline in spending, followed by the top-spending automotive industry's 15.5% cutback and an 11.4% drop in ad spend for motion pictures. Fast food was the only segment to boost spending, by 3.8%.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?